Kenya has begun administering lenacapavir, a groundbreaking HIV prevention drug, in Nairobi’s Kawangware community.
The injection, taken twice a year, reduces the risk of HIV transmission by more than 99.9%.
Health Minister Aden Duale described the rollout as “a moment of hope for thousands of Kenyan families.”
He said the drug will be free for those who receive it. Kenya is one of nine African countries selected to introduce lenacapavir, already in use in South Africa, Eswatini, and Zambia.
Kenya has about 1.3 million people living with HIV, with the highest burden among those aged 15 to 24.
Duale said, “Many of our young people still face the risk of infection… this innovation gives us renewed strength in our national fight against HIV.”
The country received 21,000 doses last week through a deal with Gilead Sciences and the Global Fund. Community health worker Carol Njomo said the drug offers greater privacy compared to regular clinic visits.
Samson Mutua, 27, became the first recipient. “This is an added protection,” he said.
Peace Lawrence, a 23-year-old sex worker, called it “a relief” since she often forgot to take oral PrEP.
Rate, Like 👍, Comment 💬, Share this article, Follow us on our social media handles, and Submit your own story to get featured and earn rewards!
